# End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)

> **NCT00374582** · NA · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 30 (estimated)

## Conditions studied

- End Stage Liver Disease

## Interventions

- **DEVICE:** Bodystat Quadscan 4000
- **DEVICE:** bodystat quadscan 400

## Key facts

- **NCT ID:** NCT00374582
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00374582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00374582, "End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00374582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*